Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Envoy's Esteem Hearing Implant Is Approvable With Conditions - FDA Panel

This article was originally published in The Gray Sheet

Executive Summary

Envoy Medical's Esteem totally implantable hearing system should be approved, with conditions, to treat moderate to severe hearing loss, FDA's Ear, Nose and Throat Devices Panel recommended Dec. 18

You may also be interested in...



Envoy Medical's Esteem Totally Implantable Hearing Aid Gains PMA Approval

Envoy Medical will conduct two post-market studies of its Esteem fully implantable hearing system to further assess long-term effectiveness and its potential to cause facial paralysis. The device gained PMA approval March 17

Envoy Medical's Esteem Totally Implantable Hearing Aid Gains PMA Approval

Envoy Medical will conduct two post-market studies of its Esteem fully implantable hearing system to further assess long-term effectiveness and its potential to cause facial paralysis. The device gained PMA approval March 17

Sonova Buys InSound, Eyes Lyric Hearing Aid Sales Of $300 Mil. By 2015

Swiss hearing aid maker Sonova expects sales of its newly acquired Lyric "invisible" hearing aid to reach $200 million to $300 million by 2015. The firm acquired Lyric developer InSound Medical on Jan. 6 for $75 million, plus milestone payments

Related Content

Topics

UsernamePublicRestriction

Register

MT028299

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel